14/11/2002

Notice of EGM 2002

14/11/2002

Resignation of board member 2002

13/11/2002

Publication of independent long-term study on Colostrinin™ shows positive results

24/10/2002

ReGen presents potential mode of action data for Colostrinin™ at International Conference on Alzheimer’s Disease

17/10/2002

Patent Granted 2002

12/10/2002

Directors Appointed at ReGen Therapeutics Plc

12/10/2002

Results of EGM & Analysts’ Presentation

26/09/2002

Interim Results for the 6 months to 30 June 2002

24/09/2002

Regen secures potential funding facility

17/09/2002

Update on potential funding

02/09/2002

Board Restructuring 2002

11/07/2002

Substantial Shareholding 2 – 2002

08/07/2002

Announcement 08/07/2002

19/06/2002

Substantial Shareholding 1 – 2002

10/06/2002

ReGen Therapeutics successfully completes Interim funding round

08/05/2002

Preliminary Results for the Year Ended 31 December 2001

22/03/2002

Colostrinin™ continues trends towards efficacy in latest Interim findings from Clinical trial

04/03/2002

Share Issue 2002

29/01/2002

Result of EGM 2002

16/01/2002

Board Changes 2002